• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经前临床Ⅰ期子宫内膜样腺癌患者卵巢恶性转移的术前预测因素分析。

Preoperative predictive factor analysis of ovarian malignant involvement in premenopausal patients with clinical stage I endometrioid endometrial carcinoma.

机构信息

Department of Pathology, Women's Hospital, Zhejiang University School of Medicine, Xueshi Road 1, Hangzhou, 310006, Zhejiang, People's Republic of China.

Department of Gynecologic Oncology, Women's Hospital, Zhejiang University School of Medicine, Xueshi Road 1, Hangzhou, 310006, Zhejiang, People's Republic of China.

出版信息

Sci Rep. 2021 Jan 13;11(1):1219. doi: 10.1038/s41598-020-78953-4.

DOI:10.1038/s41598-020-78953-4
PMID:33441576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7806745/
Abstract

Earlier literature suggests that ovarian preservation in young premenopausal clinical stage I endometrioid endometrial carcinoma patients does not negatively impact prognosis. The main purpose of this study was to clarify the incidence of ovarian malignant involvement in this group and further identify potential preoperative predictive factors of ovarian malignant involvement. A total of 511 premenopausal (age ≤ 50 years) patients were enrolled for the study at Women's Hospital, Zhejiang University School of Medicine, between January 2002 and December 2016. Ovarian malignant involvements were detected in 23 of the patients (4.5%). Univariate and multivariate logistic analysis validated preoperative imaging of myometrial invasion depth and preoperative serum carbohydrate antigen 125 (CA125) level as independent risk predictors of postoperative ovarian malignant involvement. Receiver operating characteristic (ROC) curves was generated for a combination of the two factors. The area under curve (AUC) was 0.772 (95% confidence interval [CI] 0.661-0.884) for the combined two factors. The incidence of postoperative ovarian malignant involvement was relatively minimal. Preoperative imaging of myometrial invasion depth and serum CA125 level were independent risk predictors of ovarian malignant involvement. These findings may facilitate preoperative counseling of patients and informed clinical decision-making on ovarian preservation in these patients.

摘要

早期文献表明,对于年轻的绝经前临床 I 期子宫内膜样腺癌患者,卵巢保留不会对预后产生负面影响。本研究的主要目的是阐明这组患者中卵巢恶性受累的发生率,并进一步确定卵巢恶性受累的潜在术前预测因素。

2002 年 1 月至 2016 年 12 月,浙江大学医学院附属妇产科医院共纳入 511 例绝经前(年龄≤50 岁)患者进行研究。23 例患者(4.5%)检测到卵巢恶性受累。单因素和多因素逻辑分析验证了术前子宫肌层浸润深度影像学和术前血清糖链抗原 125(CA125)水平是术后卵巢恶性受累的独立危险因素。绘制了这两个因素的组合的受试者工作特征(ROC)曲线。两个因素联合的曲线下面积(AUC)为 0.772(95%置信区间 [CI] 0.661-0.884)。术后卵巢恶性受累的发生率相对较低。术前子宫肌层浸润深度影像学和血清 CA125 水平是卵巢恶性受累的独立危险因素。这些发现可能有助于对患者进行术前咨询,并为这些患者的卵巢保留做出知情的临床决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c1/7806745/8121071c5bab/41598_2020_78953_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c1/7806745/c717d38f47a5/41598_2020_78953_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c1/7806745/8121071c5bab/41598_2020_78953_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c1/7806745/c717d38f47a5/41598_2020_78953_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85c1/7806745/8121071c5bab/41598_2020_78953_Fig2_HTML.jpg

相似文献

1
Preoperative predictive factor analysis of ovarian malignant involvement in premenopausal patients with clinical stage I endometrioid endometrial carcinoma.绝经前临床Ⅰ期子宫内膜样腺癌患者卵巢恶性转移的术前预测因素分析。
Sci Rep. 2021 Jan 13;11(1):1219. doi: 10.1038/s41598-020-78953-4.
2
Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients.年轻及绝经前子宫内膜样子宫内膜癌患者卵巢受累的危险因素。
Eur J Obstet Gynecol Reprod Biol. 2018 Mar;222:151-154. doi: 10.1016/j.ejogrb.2018.01.030. Epub 2018 Jan 31.
3
The analysis of preoperative or intraoperative factors in predicting the escalation of surgical pathological staging of patients with clinical stage I endometrioid carcinoma: A retrospective clinical study.分析临床 I 期子宫内膜样癌患者手术病理分期升级的术前或术中因素:一项回顾性临床研究。
Medicine (Baltimore). 2024 Mar 15;103(11):e37465. doi: 10.1097/MD.0000000000037465.
4
The Value of Preoperative CA 125 Levels in Prediction of Myometrial Invasion in Patients with Early-stage Endometrioid- type Endometrial Cancer.术前CA 125水平在早期子宫内膜样型子宫内膜癌患者子宫肌层浸润预测中的价值
Asian Pac J Cancer Prev. 2016;17(2):497-501. doi: 10.7314/apjcp.2016.17.2.497.
5
Estrogen/Progesterone Receptor Expression and Cancer Antigen 125 Level as Preoperative Predictors to Estimate Lymph Node Metastasis in Endometrioid Endometrial Cancer.雌激素/孕激素受体表达和癌抗原 125 水平作为术前预测指标,用于评估子宫内膜样型子宫内膜癌的淋巴结转移。
Int J Gynecol Pathol. 2024 Jul 1;43(4):316-325. doi: 10.1097/PGP.0000000000000984. Epub 2023 Sep 8.
6
Risk-stratifying clinicopathologic criteria for ovarian preservation in premenopausal women with early stage low-risk endometrial cancer.早期低风险子宫内膜癌绝经前女性卵巢保留的风险分层临床病理标准。
Int J Gynaecol Obstet. 2020 Sep;150(3):385-391. doi: 10.1002/ijgo.13254. Epub 2020 Jun 26.
7
HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status.HE4 和 CA125 作为子宫内膜样腺癌术前淋巴结转移的风险分层因子:一项具有淋巴结状态组织学证据的队列回顾性研究。
Gynecol Oncol. 2021 Feb;160(2):514-519. doi: 10.1016/j.ygyno.2020.11.004. Epub 2020 Nov 16.
8
Tumour-free distance from serosa is a better prognostic indicator than depth of invasion and percentage myometrial invasion in endometrioid endometrial cancer.在子宫内膜样腺癌中,浆膜无肿瘤距离比浸润深度和子宫肌层浸润百分比更能预示预后。
BJOG. 2012 Sep;119(10):1162-70. doi: 10.1111/j.1471-0528.2012.03427.x. Epub 2012 Jul 17.
9
A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.一种新型的子宫内膜样腺癌淋巴扩散多变量预测模型:淋巴结转移风险指数。
Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:310-315. doi: 10.1016/j.ejogrb.2019.07.015. Epub 2019 Jul 25.
10
Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance.子宫内膜癌术前宫颈细胞学检查及其临床病理相关性。
Gynecol Oncol. 1999 Mar;72(3):273-7. doi: 10.1006/gyno.1998.5244.

引用本文的文献

1
Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation.分子和病理数据指导子宫内膜样子宫内膜癌患者选择卵巢保留。
Int J Gynecol Cancer. 2024 May 6;34(5):697-704. doi: 10.1136/ijgc-2023-005194.

本文引用的文献

1
Improved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort study.CA-125 改善低级别子宫内膜癌的术前风险分层:一项多中心前瞻性队列研究。
J Gynecol Oncol. 2019 Sep;30(5):e70. doi: 10.3802/jgo.2019.30.e70.
2
Risk-based stratification of carcinomas concurrently involving the endometrium and ovary.同时累及子宫内膜和卵巢的癌的基于风险的分层。
Gynecol Oncol. 2019 Jan;152(1):38-45. doi: 10.1016/j.ygyno.2018.10.033. Epub 2018 Nov 6.
3
Risk factors for endometrial cancer: An umbrella review of the literature.
子宫内膜癌的危险因素:文献综述的伞状评价。
Int J Cancer. 2019 Oct 1;145(7):1719-1730. doi: 10.1002/ijc.31961. Epub 2019 Feb 20.
4
Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients.年轻及绝经前子宫内膜样子宫内膜癌患者卵巢受累的危险因素。
Eur J Obstet Gynecol Reprod Biol. 2018 Mar;222:151-154. doi: 10.1016/j.ejogrb.2018.01.030. Epub 2018 Jan 31.
5
Synchronous tumours of the female reproductive tract.女性生殖系统同步肿瘤。
Pathology. 2018 Feb;50(2):214-221. doi: 10.1016/j.pathol.2017.10.007. Epub 2017 Dec 14.
6
Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer.I期子宫内膜样子宫内膜癌合并同期I期子宫内膜样卵巢癌女性的预后。
Gynecol Oncol. 2017 Dec;147(3):558-564. doi: 10.1016/j.ygyno.2017.09.027. Epub 2017 Oct 4.
7
Ovarian preservation improves overall survival in young patients with early-stage endometrial cancer.保留卵巢可提高早期子宫内膜癌年轻患者的总生存率。
Oncotarget. 2017 Jun 7;8(35):59940-59949. doi: 10.18632/oncotarget.18404. eCollection 2017 Aug 29.
8
The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review.卵巢转移性肿瘤的发病机制、诊断及管理:全面综述
Clin Exp Metastasis. 2017 Jun;34(5):295-307. doi: 10.1007/s10585-017-9856-8. Epub 2017 Jul 20.
9
The role of biomarkers in the management of epithelial ovarian cancer.生物标志物在上皮性卵巢癌管理中的作用。
Expert Rev Mol Diagn. 2017 Jun;17(6):577-591. doi: 10.1080/14737159.2017.1326820. Epub 2017 May 15.
10
The Role of CA 125 as Tumor Marker: Biochemical and Clinical Aspects.CA 125作为肿瘤标志物的作用:生化及临床方面
Adv Exp Med Biol. 2015;867:229-44. doi: 10.1007/978-94-017-7215-0_14.